中国医院用药评价与分析
中國醫院用藥評價與分析
중국의원용약평개여분석
Evaluation and Analysis of Drug-Use in Hospitals of China
2015年
8期
1079-1081
,共3页
注射用血凝酶%用药频度%药物利用指数%合理用药
註射用血凝酶%用藥頻度%藥物利用指數%閤理用藥
주사용혈응매%용약빈도%약물이용지수%합리용약
Hemocoagulase atrox for injection%DDDs%DUI%Rational drug use
目的:了解常州市第二人民医院(以下简称"我院")注射用血凝酶的使用现状,为临床合理用药提供参考. 方法:对2013年5月-2014年4月我院出院患者使用的注射用血凝酶的剂量、用药频度、药物利用指数及临床应用的合理性等进行回顾性分析. 结果:我院注射用血凝酶DDDs较高的科室为肝胆外科、泌尿外科、消化内科,主要用于消化道出血、呼吸道出血、肿瘤引起的出血及预防外科手术术中和术后出血等;大部分科室注射用血凝酶的药物利用指数>1,说明其日剂量偏大;在适应证、用法与用量、用药疗程等方面存在不合理用药情况. 结论:我院注射用血凝酶的临床应用存在诸多不合理之处,需加强管理.
目的:瞭解常州市第二人民醫院(以下簡稱"我院")註射用血凝酶的使用現狀,為臨床閤理用藥提供參攷. 方法:對2013年5月-2014年4月我院齣院患者使用的註射用血凝酶的劑量、用藥頻度、藥物利用指數及臨床應用的閤理性等進行迴顧性分析. 結果:我院註射用血凝酶DDDs較高的科室為肝膽外科、泌尿外科、消化內科,主要用于消化道齣血、呼吸道齣血、腫瘤引起的齣血及預防外科手術術中和術後齣血等;大部分科室註射用血凝酶的藥物利用指數>1,說明其日劑量偏大;在適應證、用法與用量、用藥療程等方麵存在不閤理用藥情況. 結論:我院註射用血凝酶的臨床應用存在諸多不閤理之處,需加彊管理.
목적:료해상주시제이인민의원(이하간칭"아원")주사용혈응매적사용현상,위림상합리용약제공삼고. 방법:대2013년5월-2014년4월아원출원환자사용적주사용혈응매적제량、용약빈도、약물이용지수급림상응용적합이성등진행회고성분석. 결과:아원주사용혈응매DDDs교고적과실위간담외과、비뇨외과、소화내과,주요용우소화도출혈、호흡도출혈、종류인기적출혈급예방외과수술술중화술후출혈등;대부분과실주사용혈응매적약물이용지수>1,설명기일제량편대;재괄응증、용법여용량、용약료정등방면존재불합리용약정황. 결론:아원주사용혈응매적림상응용존재제다불합리지처,수가강관리.
OBJECTIVE:To investigate the application of hemocoagulase atrox for injection in the Second People's Hospital of Changzhou ( hereinafter referred to as"our hospital") , and to provide reference for the rational drug use in clinic. METHODS:Retrospective analysis of application of hemocoagulase atrox for injection on the discharged patients in our hospital from May 2013 to Apr. 2014 was conducted in respect of dosage, digital data display system(DDDs), drug use index ( DUI ) and the rationality of clinic application. RESULTS: Departments with higher DDDs of hemocoagulase atrox for injection were hepatobiliary surgery, department of urology and department of internal medicine, which mainly focus on the treatment of hemorrhage of digestive tract, hemorrhage from respiratory tract, bleeding caused by tumor and prevention of surgical intraoperative and postoperative bleeding etc. Most departments' DUI >1, which showed that described daily dose was too large. Unreasonable situations appeared in the medication indications, usage and dosage, drug treatment and some other aspects. CONCLUSIONS:As for the application of hemocoagulase atrox for injection in our hospital, there are many unreasonable aspects, which needs the further management.
